Phase 0 evidence
3 / 3
Real SimpleFold-100M public-tunnel predictions completed on engineering targets.
Phase 1 / pre-benchmark protocol
A frozen-methods draft for turning the portable lab into a publishable first paper without overclaiming beyond the evidence.
3 / 3
Real SimpleFold-100M public-tunnel predictions completed on engineering targets.
8
Phase 1A is now frozen as a SimpleFold-3B first paper unit.
manual
No-fixture SimpleFold recipe curation is complete; autonomous Reader remains a companion-methods target.
24 / 24
RCSB-selected candidate chains passed PDB+FASTA fetch checks; pending biological review.
5
Install-card templates exist for SimpleFold, ESMFold, chai-mlx, Protenix, and Boltz-2.
PDB:CHAIN
The runner now supports explicit chain labels while preserving Phase 0 PDB-only fixtures.
280 s
The long target timed out publicly but completed through direct local prediction.
exec
Mid CLI repeat captured route/cache/progress metadata in the card.
3x
Same-target CLI smokes now define the timing, memory, and confidence reporting rule.
3
Three provisional SimpleFold-3B targets have real prediction and scoring cards.
The first paper is now scoped to a smaller, publishable unit: an 8-target SimpleFold-3B benchmark frozen on 2026-05-17. The public protocol lives at Phase 1A protocol, with manifests at CSV and JSON. The original 24-target/multi-model plan remains Phase 1B.
Which open protein-structure prediction systems can a single researcher actually install, run, score, and audit on a 128 GB M3 Max workstation?
| Dimension | Minimum | Expansion |
|---|---|---|
| Targets | 8 frozen Phase 1A chains | 24-100 chains |
| Core models | 1 for Phase 1A | 3-6 |
| Repeats | 1 deterministic seed | 3 seeds / ensembles where supported |
| Metrics | lDDT, TM-score, pLDDT, wall-clock, peak memory, failure tag | Calibration and per-bin analyses |
| Output | Workshop paper + bioRxiv + public atlas packet | Journal extension |
| Bin | Count | Rationale |
|---|---|---|
| Short proteins, 30-80 aa | 6 | Fast sanity and fold coverage without reusing Phase 0 targets. |
| Mid proteins, 150-300 aa | 9 | Main quality and throughput anchor. |
| Long proteins, 500-800 aa | 6 | Memory and runtime stress. |
| Hard / disorder-rich cases | 3 | Failure-mode coverage, not a standalone model ranking. |
The first reproducible candidate set was generated from RCSB Search/Data APIs with release dates from 2025-10-01 through 2026-05-13. It excludes the Phase 0 engineering targets and marks every row as needs_biological_review. Technical fetch checks passed for all 24 rows: downloadable .pdb, selected chain present in ATOM/HETATM records, and matching FASTA chain/header.
| Bin | Count | Public artifact |
|---|---|---|
| short | 6 | CSV |
| mid | 9 | JSON |
| long | 6 | CSV |
| hard | 3 | JSON |
The enriched target review sheet flags antibody-heavy contexts, complex-derived chains, NMR references, membrane hints, and low-resolution references before promotion to the final manifest. The target triage layer converts those flags into provisional keep, human-review, and replacement-recommended categories.
| Tier | Model | Phase 1 role | Required outcome |
|---|---|---|---|
| Core | SimpleFold-3B | Native MLX anchor. | Run full Phase 1A frozen set; document any target-level failure. |
| Core | ESMFold | Mature non-AF3 baseline. | Run where install path is clean; report as baseline if needed. |
| Core | Chai-1 via chai-mlx | Community MLX port. | Run documented install and inference attempt; tag port failures precisely. |
| Attempt | Protenix-v1 | Open AF3-class model with uncertain Apple Silicon path. | Either run or produce reproducible port_unavailable / dependency_missing finding. |
| Optional | Boltz-2 | Stress case because affinity scope and CUDA orientation may confound the core question. | Include only if MPS path is stable enough to avoid attribution confusion. |
pilot/data/test_set_v1_phase1a.csv. Complete.Allowed: viability under this exact frozen protocol, model-specific run/fail status, quality and throughput on held-out targets, and public auditability. Disallowed: Apple Silicon beats CUDA, model quality rankings beyond the target set, or SimpleFold paper reproduction without comparable inference and published-metric comparison.
docs/17_phase1_protocol.mddocs/18_phase1_target_freeze.mddocs/28_simplefold3b_repeat_cache_protocol.mddocs/29_no_fixture_manual_reader.mddocs/30_phase1_target_review_triage.mddocs/31_simplefold3b_phase1_benchmark_slices.mddocs/33_phase1a_frozen_benchmark_protocol.mdpilot/data/test_set_v1_phase1a.csvpilot/fixtures/phase1a/pilot/data/model_matrix_v1.csvpilot/data/test_set_v1_candidates.csv